These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35986606)

  • 1. Fibrinogen for the prediction of severe maternal complications in placental abruption with fetal death after 24 weeks of gestation.
    Atallah A; Piccin G; Dubernard G; Abdul-Hay MJ; Cortet M; Huissoud C
    Int J Gynaecol Obstet; 2023 Mar; 160(3):900-905. PubMed ID: 35986606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The indicators for early blood transfusion in patients with placental abruption with intrauterine fetal death: a retrospective review.
    Sano Y; Kasai M; Shinoda S; Miyagi E; Aoki S
    BMC Pregnancy Childbirth; 2022 Nov; 22(1):847. PubMed ID: 36397012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal outcomes of placental abruption with intrauterine fetal death and delivery routes: A nationwide observational study.
    Wada Y; Takahashi H; Sasabuchi Y; Usui R; Ogoyama M; Suzuki H; Ohkuchi A; Fujiwara H
    Acta Obstet Gynecol Scand; 2023 Jun; 102(6):708-715. PubMed ID: 37019855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe placental abruption: clinical definition and associations with maternal complications.
    Ananth CV; Lavery JA; Vintzileos AM; Skupski DW; Varner M; Saade G; Biggio J; Williams MA; Wapner RJ; Wright JD
    Am J Obstet Gynecol; 2016 Feb; 214(2):272.e1-272.e9. PubMed ID: 26393335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report.
    Honda M; Matsunaga S; Era S; Takai Y; Baba K; Seki H
    J Med Case Rep; 2014 Dec; 8():461. PubMed ID: 25532532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-delivery fibrinogen predicts adverse maternal or neonatal outcomes in patients with placental abruption.
    Wang L; Matsunaga S; Mikami Y; Takai Y; Terui K; Seki H
    J Obstet Gynaecol Res; 2016 Jul; 42(7):796-802. PubMed ID: 27075198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Neonatal/Maternal Morbidity and Mortality in African American Women with Placental Abruption.
    Elkafrawi D; Sisti G; Araji S; Khoury A; Miller J; Rodriguez Echevarria B
    Medicina (Kaunas); 2020 Apr; 56(4):. PubMed ID: 32295061
    [No Abstract]   [Full Text] [Related]  

  • 8. The comparison of placental abruption coupled with and without preeclampsia and/or intrauterine growth restriction in singleton pregnancies.
    Ni S; Wang X; Cheng X
    J Matern Fetal Neonatal Med; 2021 May; 34(9):1395-1400. PubMed ID: 31248311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine fetal death and delivery complications associated with coagulopathy: a retrospective analysis of 104 cases.
    Tempfer CB; Brunner A; Bentz EK; Langer M; Reinthaller A; Hefler LA
    J Womens Health (Larchmt); 2009 Apr; 18(4):469-74. PubMed ID: 19361313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion and hematologic indices in cases of stillbirth due to placental abruption.
    White A; Pruszynski J; Williams R; Duryea EL
    Am J Obstet Gynecol; 2023 Dec; 229(6):677.e1-677.e10. PubMed ID: 37364802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of risk factors for uteroplacental apoplexy complicating placental abruption].
    Cheng WW; Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):593-6. PubMed ID: 19087494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta in intrauterine fetal demise (IUFD): a comprehensive study from a tertiary care hospital.
    Manocha A; Ravikumar G; Crasta J
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3939-3947. PubMed ID: 29792056
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential prevention of stillbirth caused by placental abruption: a regional population-based study in Japan.
    Kasahara M; Koshida S; Tokoro S; Katsura D; Tsuji S; Murakami T; Takahashi K
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2321485. PubMed ID: 38403932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious maternal complications after early preterm delivery (24-33 weeks' gestation).
    Reddy UM; Rice MM; Grobman WA; Bailit JL; Wapner RJ; Varner MW; Thorp JM; Leveno KJ; Caritis SN; Prasad M; Tita AT; Saade GR; Sorokin Y; Rouse DJ; Blackwell SC; Tolosa JE; ;
    Am J Obstet Gynecol; 2015 Oct; 213(4):538.e1-9. PubMed ID: 26164696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of pre-delivery laboratory test results for the severity of placental abruption and pregnancy outcome.
    Su J; Yang Y; Cao Y; Yin Z
    Placenta; 2021 Jan; 103():220-225. PubMed ID: 33166877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
    Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fetal death in placental abruption: comparison of two different time periods].
    Cabar FR; Nomura RM; Machado TR; Zugaib M
    Rev Assoc Med Bras (1992); 2008; 54(3):256-60. PubMed ID: 18604405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental Histopathology and Pregnancy Outcomes in "Early" vs. "Late" Placental Abruption.
    Gonen N; Levy M; Kovo M; Schreiber L; Noy LK; Volpert E; Bar J; Weiner E
    Reprod Sci; 2021 Feb; 28(2):351-360. PubMed ID: 32809128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of fetal death associated with maternal drug dependence and placental abruption: a population-based study.
    McDonald SD; Vermeulen MJ; Ray JG
    J Obstet Gynaecol Can; 2007 Jul; 29(7):556-559. PubMed ID: 17623568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approach to the risk variables for administration of fibrinogen in patients with postpartum hemorrhage by using cluster analysis.
    Yilmaz EPT; Celik Y; Topdagi YE; Guzel AI; Al RA
    Int J Gynaecol Obstet; 2021 Feb; 152(2):256-261. PubMed ID: 32967036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.